SS Innovations International (SSII) Non-Current Deffered Revenue (2022 - 2026)
SS Innovations International (SSII) reported Non-Current Deffered Revenue of $7.5 million for Q1 2026, up 38.78% on a YoY basis from $5.4 million in Q1 2025, and up 5.06% sequentially from $7.1 million in Q4 2025.
SS Innovations International (SSII) Non-Current Deffered Revenue (2022 - 2026) Analysis & Trends
SS Innovations International (SSII) has 5 years of Non-Current Deffered Revenue data on file, last reported at $7.5 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deffered Revenue rose 38.78% year-over-year to $7.5 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (up 38.78% YoY), and the FY2025 full-year result was $7.1 million, up 38.0% from the prior year.
- Non-Current Deffered Revenue rose to $7.5 million in Q1 2026, from $7.1 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $7.5 million in Q1 2026 to a low of $42141.0 in Q4 2022.
- A 5-year average of $3.9 million and a median of $4.3 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue surged 2128.59% in 2023 and surged 38.0% in 2025, its largest moves.
- Tracing SSII's Non-Current Deffered Revenue over 5 years: stood at $42141.0 in 2022, then surged by 2128.59% to $939150.0 in 2023, then jumped by 450.92% to $5.2 million in 2024, then soared by 38.0% to $7.1 million in 2025, then grew by 5.06% to $7.5 million in 2026.
- Business Quant data shows SSII's Non-Current Deffered Revenue at $7.5 million in Q1 2026, $7.1 million in Q4 2025, and $6.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 7.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 7.14 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 5.78 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 939,150.00 |
| Sep 30, 2023 | 796,235.00 |
| Jun 30, 2023 | 348,993.00 |
| Dec 31, 2022 | 42,141.00 |